Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.005 USD | -2.20% | -6.75% | +18.91% |
05-15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
05-09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.91% | 735M | |
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+1.14% | 22.57B | |
-11.14% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Transcript : Wave Life Sciences Ltd., Q3 2022 Earnings Call, Nov 10, 2022